Literature DB >> 32097111

Crimean-Congo Hemorrhagic Fever Virus Endemicity in United Arab Emirates, 2019.

Jeremy V Camp, Dafalla O Kannan, Babiker Mohammed Osman, Moayyed Sher Shah, Brigitte Howarth, Tamer Khafaga, Pia Weidinger, Noushad Karuvantevida, Jolanta Kolodziejek, Hessa Mazrooei, Nadine Wolf, Tom Loney, Norbert Nowotny.   

Abstract

We conducted a cross-sectional survey of Crimean-Congo hemorrhagic fever virus (CCHFV) in dromedary camels and attached ticks at 3 locations in the United Arab Emirates. Results revealed a high prevalence of CCHFV-reactive antibodies in camels and viral RNA in ticks and camel serum, suggesting the virus is endemic in this country.

Entities:  

Keywords:  Camelus; Crimean-Congo hemorrhagic fever virus; Hyalomma ticks; United Arab Emirates; dromedary camels; endemic diseases; sequencing; vector-borne infections; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32097111      PMCID: PMC7181925          DOI: 10.3201/eid2605.191414

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Crimean-Congo hemorrhagic fever virus (CCHFV; order Bunyavirales, family Nairoviridae, genus Orthonairovirus) is a geographically widespread species of tickborne virus. Enzootic transmission cycles involve livestock (cattle, sheep, goats) and tick species of the genus Hyalomma (Acari: Ixodidae) (). Spillover into humans typically occurs through tick bites; however, some severe (and even fatal) CCHFV infections have occurred as a result of exposure to blood or tissue from infected animals. The virus is genetically diverse, and evidence indicates that frequent reassortment of viral gene segments occurs, potentially as a result of animal trade between regions of Africa and Asia (,). Reports of infections in humans during 2016–2019 (–), the outbreak in the United Arab Emirates (UAE) in 1979 (), and the outbreak in Oman during 1994–1995 () suggest that CCHFV is present in the Arabian Peninsula. However, little is known about enzootic transmission and the frequency of importation into this region. Therefore, we conducted a cross-sectional survey of ticks and dromedary camels in the UAE to determine exposure status and detect active CCHFV infections. We collected whole blood samples from camels at 3 sites within the UAE that differed in camel use: a family farm, a desert conservation reserve with multiple tour operators, and a large livestock market (Appendix). We found CCHFV antibodies in the serum samples of 67% (84/125) of camels. CCHFV antibody prevalence was highest in older camels (96% in camels >10 years of age), and no difference in antibody prevalence was detected between sexes (68% [51/75] male, 71% [29/41] female) (Appendix Table 1). The prevalence of reactive antibodies differed between sampling locations, potentially because of differences in animal ages at the respective sites. We removed 314 adult ticks and 33 tick nymphs (0–5 ticks/camel) from camels and identified the species under a stereomicroscope. Most (99%, 311/314) adults were Hyalomma dromedarii ticks, and 3 were H. scupense ticks. Two pools of adult H. dromedarii ticks (1 containing 3 males and the other containing 1 male) from 2 separate camels (both 6-year-old females, one of which was antibody positive) and serum samples from 2 camels (a 3-year-old female and 2-year-old male, both antibody negative) were positive for CCHFV nucleic acid (Appendix Table 2). These 4 camels were all from the livestock market but originated from different regions of the UAE. The 2 camels with CCHFV RNA–positive serum were only briefly at the livestock market (for 1 and 2 days), and the 2 with CCHFV RNA–positive ticks were housed at the market for 7 and 41 days. We performed 2 conventional reverse transcription PCRs on the RNA-positive serum samples and on each tick from the 2 RNA-positive pools, 1 amplifying a 492-bp portion of the viral small (S) segment and 1 amplifying a 672-bp portion of the viral medium (M) segment (Appendix). We then subjected these PCR products to Sanger sequencing (GenBank accession nos. MN516481–8; Appendix Table 3). The S segment sequences from 3 ticks (from 2 camels) and 2 serum samples were all identical to each other, except for a single synonymous substitution in the sequence from 1 serum sample; these sequences were genetically similar to sequences of isolates from West and South Africa (group III; Figure, panel A). We obtained the M segment sequences from only 3 ticks from 2 camels. These sequences were 85% identical to available sequences in GenBank, and the isolate with the closest identity (AP92, GenBank accession no. DQ211625) was from Greece (Figure panel B). Thus, the 2019 UAE isolates did not fall within previously defined phylogenetic groups ().
Figure

Molecular phylogeny of Crimean-Congo hemorrhagic fever viruses from dromedary camel serum samples and ticks (green circles, thick branches), United Arab Emirates, 2019. A maximum-likelihood analysis of a 492-nt sequence of the viral small (S) segment (A) and 672-nt sequence of the viral medium (M) segment (B) were performed. Viruses are labeled by GenBank accession number, country of origin, isolate name, and year of identification and are colored according to S segment lineages following the group nomenclature (): group I, West Africa 1; group II, Democratic Republic of the Congo; group III, South Africa and West Africa 2; group IV, Asia and the Middle East; group V, Europe and Turkey; group VI, Greece; and group VII (M segment only). Numbers beside branches are bootstrap values from 500 bootstrap replicates; only values >60% are shown. Scale bars indicate number of substitutions per site.

Molecular phylogeny of Crimean-Congo hemorrhagic fever viruses from dromedary camel serum samples and ticks (green circles, thick branches), United Arab Emirates, 2019. A maximum-likelihood analysis of a 492-nt sequence of the viral small (S) segment (A) and 672-nt sequence of the viral medium (M) segment (B) were performed. Viruses are labeled by GenBank accession number, country of origin, isolate name, and year of identification and are colored according to S segment lineages following the group nomenclature (): group I, West Africa 1; group II, Democratic Republic of the Congo; group III, South Africa and West Africa 2; group IV, Asia and the Middle East; group V, Europe and Turkey; group VI, Greece; and group VII (M segment only). Numbers beside branches are bootstrap values from 500 bootstrap replicates; only values >60% are shown. Scale bars indicate number of substitutions per site. Our data indicate that exposure to CCHFV is common among camels in the UAE, and transmission to camels might be occurring via native infected H. dromedarii ticks. A previous survey of UAE livestock that occurred shortly after the 1994–1995 outbreak ruled out camels and camel ticks as CCHFV reservoirs (). Our data might indicate increased transmission activity in the region, potentially explaining the human case in Sharjah, UAE, in August 2019 associated with handling infected meat (). The largest outbreak of CCHFV infection in the UAE (1994–1995) was associated with a high case-fatality ratio (73%) and was limited to abattoir workers (,); however, hospital outbreaks have also previously occurred in the UAE (). All previously characterized CCHFV isolates from the Arabian Peninsula and the Middle East (including viruses from the UAE and Oman) were genetically similar to each other, clustering together according to the S segment (group IV, Figure panel A). The M segments of the isolates from UAE and Oman were similar to those of viruses from Asia, the Middle East, West Africa, and South Africa (Figure panel B) (,,). Overall, the data suggest that CCHFV is endemic in the UAE, where enzootic transmission cycles involve camels and camel ticks.

Appendix

More information on Crimean-Congo hemorrhagic fever virus endemic in United Arab Emirates, 2019.
  8 in total

1.  Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Authors:  Varough M Deyde; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Crimean-Congo haemorrhagic fever in Oman.

Authors:  T F Schwarz; H Nitschko; G Jäger; H Nsanze; M Longson; R N Pugh; A K Abraham
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

3.  Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates.

Authors:  L L Rodriguez; G O Maupin; T G Ksiazek; P E Rollin; A S Khan; T F Schwarz; R S Lofts; J F Smith; A M Noor; C J Peters; S T Nichol
Journal:  Am J Trop Med Hyg       Date:  1997-11       Impact factor: 2.345

4.  Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital.

Authors:  M N Suleiman; J M Muscat-Baron; J R Harries; A G Satti; G S Platt; E T Bowen; D I Simpson
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

Review 5.  Crimean-Congo hemorrhagic fever and expansion from endemic regions.

Authors:  Jessica R Spengler; Éric Bergeron; Christina F Spiropoulou
Journal:  Curr Opin Virol       Date:  2019-01-16       Impact factor: 7.090

6.  Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates.

Authors:  T F Schwarz; H Nsanze; A M Ameen
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 7.455

7.  Clinical and molecular epidemiology of Crimean-Congo hemorrhagic fever in Oman.

Authors:  Seif S Al-Abri; Roger Hewson; Hanan Al-Kindi; Idris Al-Abaidani; Amina Al-Jardani; Amal Al-Maani; Samira Almahrouqi; Barry Atkinson; Adil Al-Wahaibi; Bader Al-Rawahi; Shyam Bawikar; Nicholas J Beeching
Journal:  PLoS Negl Trop Dis       Date:  2019-04-25

8.  Crimean-Congo Hemorrhagic Fever in Migrant Worker Returning from Oman to India, 2016.

Authors:  Pragya D Yadav; Sachin Thacker; Deepak Y Patil; Rajlaxmi Jain; Devendra T Mourya
Journal:  Emerg Infect Dis       Date:  2017-06       Impact factor: 6.883

  8 in total
  7 in total

1.  In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.

Authors:  Akinyemi Ademola Omoniyi; Samuel Sunday Adebisi; Sunday Abraham Musa; James Oliver Nzalak; Zainab Mahmood Bauchi; Kerkebe William Bako; Oluwasegun Davis Olatomide; Richard Zachariah; Jens Randel Nyengaard
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

2.  Identification of a novel lineage of Crimean-Congo haemorrhagic fever virus in dromedary camels, United Arab Emirates.

Authors:  Abdelmalik I Khalafalla; Yan Li; Anna Uehara; Nasareldien A Hussein; Jing Zhang; Ying Tao; Eric Bergeron; Ibrahim H Ibrahim; Mohamed A Al Hosani; Mohd F Yusof; Zulaikha M Alhammadi; Saeed M Alyammahi; Esmat F Gasim; Hassan Z A Ishag; Farida A L Hosani; Susan I Gerber; Salama S Almuhairi; Suxiang Tong
Journal:  J Gen Virol       Date:  2021-02       Impact factor: 3.891

Review 3.  Ticks and Tick-Borne Diseases of Livestock in the Middle East and North Africa: A Review.

Authors:  Nighat Perveen; Sabir Bin Muzaffar; Mohammad Ali Al-Deeb
Journal:  Insects       Date:  2021-01-19       Impact factor: 2.769

4.  Crimean-Congo Hemorrhagic Fever Virus Past Infections Are Associated with Two Innate Immune Response Candidate Genes in Dromedaries.

Authors:  Sara Lado; Jan Futas; Martin Plasil; Tom Loney; Pia Weidinger; Jeremy V Camp; Jolanta Kolodziejek; Dafalla O Kannan; Petr Horin; Norbert Nowotny; Pamela A Burger
Journal:  Cells       Date:  2021-12-21       Impact factor: 7.666

5.  Crimean-Congo hemorrhagic fever virus in ticks collected from imported camels in Egypt.

Authors:  Hager A Bendary; Fatma Rasslan; Milton Wainwright; Saleh Alfarraj; Ali M Zaki; Abeer K Abdulall
Journal:  Saudi J Biol Sci       Date:  2021-12-21       Impact factor: 4.052

6.  Assessing Temporal Changes in Microbial Communities in Hyalomma dromedarii Collected From Camels in the UAE Using High-Throughput Sequencing.

Authors:  Nighat Perveen; Sabir Bin Muzaffar; Ranjit Vijayan; Mohammad Ali Al-Deeb
Journal:  Front Vet Sci       Date:  2022-03-31

7.  Crimean-Congo hemorrhagic fever in the Arab world: A systematic review.

Authors:  Nighat Perveen; Gulfaraz Khan
Journal:  Front Vet Sci       Date:  2022-09-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.